KATHLEEN CANSLER: Open Payments
NPI 1801931761 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$487 in 20 payments from 5 companies in 2025. Trend: 2023 $1,451 · 2024 $533 · 2025 $487
Food & beverage: $487
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $216 |
| Aimmune Therapeutics, Inc. | 9 | $150 |
| Intra-Sana Laboratories | 3 | $56 |
| Merck Sharp & Dohme LLC | 2 | $50 |
| Amgen Inc. | 1 | $16 |
Products named: CAPLYTA, ZENPEP, RELTONE 200 MG, VOWST, CAPVAXIVE, VERQUVO, OTEZLA.
Industry payments across NV — which companies pay providers there.
